NDC 0406-8020 – Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC0406-8020

Product details

Brand name
Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate
Generic name
Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate
Labeler
SpecGx LLC
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA207000
Marketed since
December 13, 2017
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE →

Package NDC codes (1)

Package NDCDescriptionSince
0406-8020-0330 TABLET in 1 BOTTLE, PLASTIC (0406-8020-03)Dec 13, 2017

Other BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE products